FP7Индивидуална стипендия2014–2016

FTG-ABS-SEQ · Filling the Gaps, Chemo-enzymatic Approaches towards Abasic Site Sequencing

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2014-05-01 → 2016-04-30
Финансиране от ЕС
221 606 €
Участници
1
Схема
MC-IEF

Линиите свързват координатора с партньорите.

Накратко на български

Абазичните сайтове са места в ДНК, където кодиращата база е изгубена поради вредни влияния като цигаретен дим. Разбирането на това дали определени части от генома са по-податливи на тези повреди помага за изясняване на механизмите на заболеванията.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Filling the Gaps, Chemo-enzymatic Approaches towards Abasic Site Sequencing

The bio-macromolecular nucleic acids DNA and RNA are each built up from similar sets of four distinct building blocks called nucleotides. These nucleotides consist of a nucleobase that forms the coding entity, the (2’-deoxy-)ribose sugar and a phosphate group that allows for the connection of the individual nucleotides. Crucially, both DNA and RNA are post-synthetically modified by endogenous processes introducing a second layer of information into the nucleic acid, which is commonly referred to as epigenetic base modification. In mammalian DNA this occurs through methylation of 2’-deoxycytidine, forming 5-methyl-2’-deoxycytidine which has been linked to the crucially important gene expression for correct cellular function and when disregulated becomes a hallmark of disease. Unfortunately the DNA is also constantly modified by other events that damage the molecule carrying the all important genetic information; these events can be from both endogenous (e.g. reactive oxygen species) and exogenous (e.g. tobacco smoke) sources. This may lead to ‘erasure’ of genetic information by the formation of a so-called abasic site where the coding nucleobase has been removed, leaving an aldehyde residue at this site. Additionally, spontaneous ‘erasure’ of nucleobases does also occur making the abasic sites one of the most common occurrences of DNA damage. Surprisingly, it has so far remained elusive whether these events occur on specific sites on the genomic DNA. In other words, are certain parts of the genome more sensitive to this sort of damage? I have screened different chemical reactions to “tag” abasic site DNA damage in experiments to identify those genomic regions where such sites are present and to attempt to quantify them. Crucially, the selected chemistry should have the following properties: bio-orthogonal, selective, yield a stable intermediate, rapid and high yielding. To this end I screened hydrazines, oxy-amines and di-amines, some of which are commercially available and have been used in the past to quantify abasic sites on DNA. I have also explored the application of the so-called Pictet-Spengler (PS) reaction to tag abasic sites in DNA. By designing and synthesizing these PS probes and reacting them with short synthetic DNA it was found that this novel approach outcompetes traditional aldehyde reactive probes in terms of conversion. More importantly, the PS probe reacts at physiological pH and forms a very stable carbon-carbon bond between the tag and DNA. Having identified an efficient new chemical procedure to tag abasic sites in DNA, we set out to develop a method to enrich abasic site DNA by means of a streptavidin pulldown. To this end a biotin affinity tag was added to our PS probe. This method will allow for the determination of those sites on genomic DNA where abasic sites are present at a resolution of approximately 200 – 500 bases. By selection of optimized conditions, we have now established that >100-fold enrichment of synthetic abasic sites containing DNA can be achieved using the PS-tag in vitro. This result, one of the key objectives, is very promising and efforts to translate the conditions established in vitro to genomic DNA are the subject of ongoing research. In this respect an important hurdle that has yet to be surmounted is the optimization of PCR amplification of the enriched ‘tagged’ abasic site-containing DNA, which is crucial order for genomic scale sequencing to finally be applied. Currently we observe polymerase stalling at our PS-tagged abasic sites on synthetic oligomers when amplification for sequencing is pursued directly after enrichment. Although sequencing by means of enrichment is a common technique and has been applied to several other modifications such as N6-methyl-2’deoxyadenosine, it does not provide information on the absolute quantities of a given DNA modification/level of damage. To this end, a method was developed to enzymatically digest ‘tagged’ abasic site DNA and provide subsequent quantification by state of the art liquid chromatography - tandem mass spectrometry. Preliminary data obtained from reacting the DNA of HEK-293T cells with the PS-probe, subsequent digestion and quantification, abasic site levels of are observed at an abundance of 7 sites per 10-5 genomic nucleotides. In summary we have established novel chemistry to tag abasic sites. By using Pictet-Spengler chemistry we did not only improve reaction rates, but this chemistry can also be applied in situ due to its retained reactivity at physiological pH. Furthermore, the chemical adduct formed is hydrolytically stable, important for downstream analysis such as the performed LC-MS/MS quantitation. Finally, experiments revealed this chemistry can indeed be used to enrich abasic site-containing DNA in vitro. Towards genomic scale sequencing, final optimization of the PCR amplification of DNA enriched for abasic sites is now required.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

In this proposal a new sequencing method called abasic site sequencing: AbS-Seq will be developed and applied to the sequencing of abasic sites in context of DNA post-synthetic modifications and the position of abasic site DNA lesions on the genome.Abasic sites are places on the genome where the nucleobase has been removed. This “gap” can be a result of DNA damage due to exo- (smoke, tar) or endogenous sources (reactive oxygen species, alkylation) or can occur spontaneous in processes called de-purination/de-pyrimidination. Additionally, a set of specialized enzymes can remove a variety of modified/damaged nucleobases as part of a specialized cellular repair mechanism known as the Base Excission Repair (BER) pathway.In this proposal the sequencing of the naturally abundant abasic site DNA lesions will be investigated. The aim is to elucidate the sequence context of these DNA damages and their relation to the event of transcription. By the conversion of the small molecular probes into entities that can be used for pulldown and thus for the enrichment of abasic site containing DNA fragments, those part of the genome containing abasic sites can be sequenced. Such a strategy can be used to provide insights in the correlation between active gene expression and DNA damage in health and disease. Additionally, it is proposed to use the enzymes from the BER for the sequencing of post-synthetic DNA modifications by creating abasic sites in vitro. The same enrichment method can then be applied to map the modifications of interest on a genome scale. In addition, base resolution may be acquired by the comparison of sequencing data from native samples and the converted abasic sites.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз